Literature DB >> 15549380

Colostrum from healthy Brazilian women inhibits adhesion and contains IgA antibodies reactive with Shiga toxin-producing Escherichia coli.

Patricia Palmeira1, Solange Barros Carbonare, José Araujo Amaral, Milene Tino-De-Franco, Magda Maria Sales Carneiro-Sampaio.   

Abstract

UNLABELLED: Although Shiga toxin-producing Escherichia coli (STEC) has been isolated in Brazil, severe manifestations of the infection, such as haemorrhagic colitis and haemolytic-uraemic syndrome, are extremely rare in our population. Enteropathogenic Escherichia coli (EPEC) is the main aetiological agent of acute infantile diarrhoea in Brazil. There are many similarities between STEC and EPEC, such as the ability to produce attaching and effacing (A/E) lesions and some virulence-associated factors. Our aim was to investigate the presence of anti-STEC antibodies in healthy people living in an EPEC endemic area. Colostrum samples collected from 51 women living in low socio-economic conditions were analysed. Two STEC strains: O111:H- (Stx1) and O157:H7 (Stx2), and one EPEC strain (O111:H-) were used in the bacterial adhesion assays to HEp-2 cells, in the Stx1 and Stx2 cytotoxicity assays on Vero cells, in immunoblotting and in ELISA assays. All the samples strongly inhibited the adhesion of the three strains and contained SIgA antibodies reactive with antigens of EPEC O111:H-, STEC O111:H- and STEC O157:H7, mainly STEC and EPEC 94 kDa adhesin intimin. High titres of anti-LPS O111 antibodies were found in many samples. Nevertheless, the cytotoxic effect of both Stx1 and Stx2 on Vero cells was not neutralised by any sample.
CONCLUSION: Our results suggest that Brazilian people may be exposed to Shiga toxin-producing Escherichia colimore frequently than previously thought or alternatively there may be a cross reactive immunity between enteropathogenic Escherichia coliand Shiga toxin-producing Escherichia coli.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15549380     DOI: 10.1007/s00431-004-1561-3

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

1.  Inhibition of enteropathogenic Escherichia coli adhesion to HEp-2 cells by colostrum and milk from mothers delivering low-birth-weight neonates.

Authors:  M T Delneri; S B Carbonare; M L Silva; P Palmeira; M M Carneiro-Sampaio
Journal:  Eur J Pediatr       Date:  1997-06       Impact factor: 3.183

2.  Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers.

Authors:  T Wuorimaa; R Dagan; J Eskola; J Janco; H Ahman; O Leroy; H Käyhty
Journal:  Pediatr Infect Dis J       Date:  2001-03       Impact factor: 2.129

3.  Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock.

Authors:  A Donohue-Rolfe; G T Keusch
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

Review 4.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery.

Authors:  M M Levine; J McEwen; G Losonsky; M Reymann; I Harari; J E Brown; D N Taylor; A Donohue-Rolfe; D Cohen; M Bennish
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

6.  Antibody responsiveness to the enteropathogenic Escherichia coli bundle-forming pilus subunit A in lactating mothers and asymptomatic children.

Authors:  Regina Célia de Souza Campos Fernandes; Victor Martin Quintana Flores; Zila Sousa de Macedo; Enrique Medina-Acosta
Journal:  Eur J Pediatr       Date:  2002-07-10       Impact factor: 3.183

7.  First Shiga toxin-producing Escherichia coli isolate from a patient with hemolytic uremic syndrome, Brazil.

Authors:  Beatriz Ernestina C Guth; Renato Lopes de Souza; Tânia Mara I Vaz; Kinue Irino
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

8.  Quantitative microtiter cytotoxicity assay for Shigella toxin.

Authors:  M K Gentry; J M Dalrymple
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

9.  Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1.

Authors:  M A Karmali; M Petric; M Winkler; M Bielaszewska; J Brunton; N van de Kar; T Morooka; G B Nair; S E Richardson; G S Arbus
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

Review 10.  Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections.

Authors:  J C Paton; A W Paton
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

View more
  4 in total

1.  Passive immunity acquisition of maternal anti-enterohemorrhagic Escherichia coli (EHEC) O157:H7 IgG antibodies by the newborn.

Authors:  Patricia Palmeira; Leonardo Yu Ito; Christina Arslanian; Magda Maria Sales Carneiro-Sampaio
Journal:  Eur J Pediatr       Date:  2006-10-21       Impact factor: 3.183

2.  Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model.

Authors:  Carla Calderon Toledo; Ida Arvidsson; Diana Karpman
Journal:  Infect Immun       Date:  2011-03-14       Impact factor: 3.441

3.  Detection of secretory immunoglobulin A in human colostrum as mucosal immune response against proteins of the type III secretion system of Salmonella, Shigella and enteropathogenic Escherichia coli.

Authors:  David Durand; Theresa J Ochoa; Sicilia M E Bellomo; Carmen A Contreras; Víctor H Bustamante; Joaquim Ruiz; Thomas G Cleary
Journal:  Pediatr Infect Dis J       Date:  2013-10       Impact factor: 2.129

4.  Evaluation of colostrum as an alternative biological sample for the diagnosis of human congenital toxoplasmosis.

Authors:  Ana Carolina de Morais Oliveira; Hellen Dayane Silva Borges; Fernando Reis Carvalho; Arlindo Gomes de Macêdo; Caroline Martins Mota; Angela Maria de Morais Oliveira; Fernanda Maria Santiago; Cristina Guimarães Arantes Araújo; Deise Aparecida de Oliveira Silva; Tiago Wilson Patriarca Mineo; Vânia Olivetti Steffen Abdallah; José Roberto Mineo
Journal:  BMC Infect Dis       Date:  2015-11-14       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.